CAS No. |
518-17-2 |
英文名称 |
(S)-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one |
别名 |
Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (S)-;Indolo(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-;8,13,13b14-Tetrahydro-14-Methlindolo[23:3,4]Pyrido[2,1-b]Quinazolin-5-[7H]-One;EvodiaMine(IsoevodiaMine);8,13,13b,14-tetrahydro-14-methyl-,(S)-;Indolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one;Evodia rutaecarpa E.P.;[13bS,(+)]-8,13,13b,14-Tetrahydro-14-methylindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one |
标准英文名 |
(S)-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one |
分子式 |
C19H17N3O |
分子量 |
303.36
|
精确分子量 |
303.14
|
SMILES |
CN1C2=CC=CC=C2C(=O)N2CCC3=C(NC4=C3C=CC=C4)[C@@H]12 |
标准SMILES |
CN1[C@@H]2C3NC4C=CC=CC=4C=3CCN2C(=O)C2=CC=CC=C12 |
用途 |
Evodiamine exhibits a wide range of pharmacological activities and applications, including: anti-tumor effects by inhibiting proliferation of various cancer cells (e.g., cervical, colon, lung, melanoma, T-cell leukemia, prostate, and breast cancers); anti-Alzheimer’s activity through suppression of neuroinflammatory responses; anti-inflammatory and analgesic effects via inhibition of COX-2 and iNOS expression; cardiovascular protection, including anti-ischemic, anti-arrhythmic, and blood pressure-modulating effects; anti-obesity and hypoglycemic actions by regulating TRPV1 and CGRP expression; uterine contraction; diuretic effect; potent antibacterial activity against Escherichia coli; anthelmintic activity against Ascaris suum; gastroprotective effects such as promoting digestion, relieving dry vomiting, and reducing acid regurgitation; therapeutic potential in senile dementia and stroke; and modulation of hormone secretion and steroidogenesis. It is also used for content determination, compound identification, and pharmacological research. |
InChIKey |
TXDUTHBFYKGSAH-SFHVURJKSA-N |